Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34.7M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+1.07M
-
Total reported value, excl. options
-
$742M
-
Value change
-
+$66.5M
-
Number of buys
-
34
-
Number of sells
-
-26
-
Price
-
$56.15
Significant Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q1 2020
69 filings reported holding IGMS - IGM Biosciences, Inc. - Common Stock, par value $0.01 per share as of Q1 2020.
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 34.7M outstanding shares and own 38.21% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (3.14M shares), BAKER BROS. ADVISORS LP (3.14M shares), JANUS HENDERSON GROUP PLC (1.48M shares), RA CAPITAL MANAGEMENT, L.P. (983K shares), PRICE T ROWE ASSOCIATES INC /MD/ (818K shares), VANGUARD GROUP INC (500K shares), ALKEON CAPITAL MANAGEMENT LLC (484K shares), BlackRock Inc. (447K shares), Cormorant Asset Management, LP (426K shares), and HILLHOUSE CAPITAL ADVISORS, LTD. (350K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.